Industry experts say Western companies will need to weigh potential access to oil and gas riches against political risks and ...

We are a thoughtful and highly cooperative bunch. There is no fundraiser or charity or even local buy-nothing Facebook group ...

BP, once a champion of Net Zero, now faces investor pressure to refocus on oil and gas, signaling a potential shift away from ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $23.0 to $42.0 for BP over the last 3 months. Looking at the volume ...

The BP PLC ADR BP slid 2.18% to $34.54 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.07% to 20,056.25 and ...

BP is considering a potential sale of its lubricants business in a deal that could fetch ~$10B, Bloomberg reports.

Sanofi SNY and partner Regeneron REGN announced that the FDA has accepted their supplemental biologics license application ...

Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid If approved, Dupixent would be the first and only targeted medicine to treat BP in the US; FDA decision ...

The UK oil major faces activist pressure to retreat from a disappointing energy-transition strategy. But recent failures are ...

As the global push for clean energy accelerates, hydrogen-based technologies are at the forefront of the transition.

ET Net News Agency, 17 February 2025] UBS raised the target price for BYD Company (01211) to HKD450 from HKD327 and maintained the "buy" rating. The research house said in a year ...